Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/11/2017
SIETES contiene 92130 citas

 
 
 1 a 11 de 11 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. FDA warns about serious liver injury with Ocaliva (obeticholic acid) for rare chronic liver disease. FDA U.S. Food and Drug Administration 2017:21 de septiembre. [Ref.ID 102061]
2. Cita con resumen
Anónimo. La FDA concede la autorización acelerada a ácido obeticólico. El Global 2016:43. [Ref.ID 100409]
3.Enlace a cita original
Sampaziotis F, Griffiths WJH. Severe coagulopathy caused by rifampicin in patients with primary sclerosing cholangitis and refractory pruritus. Br J Clin Pharmacol 2012;73:826-7. [Ref.ID 92799]
4. Cita con resumen
Anónimo. Ursodeoxycholic acid: serious hepatic events. Canada. WHO Drug Information 2012;26:24. [Ref.ID 92555]
5. Cita con resumen
Anónimo. Ursodiol: association of high-dose with serious liver side effects. Canada. WHO Pharmaceuticals Newsletter 2012;1:9. [Ref.ID 92204]
6.Tiene citas relacionadas
Hawk ET, Viner JL. Chemoprevention in ulcerative colitis: narrowing the gap between clinical practice and research. Ann Intern Med 2001;134:158-60. [Ref.ID 55679]
7.Tiene citas relacionadas
Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001;134:89-95. [Ref.ID 55673]
8. Cita con resumen
Schramm C, Schirmacher P, Helmreich-Becker I, Gerken G, zum Büschenfelde KHM, Lohse AW. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series. Ann Intern Med 1999;131:943-6. [Ref.ID 48563]
9.
Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs 1999;57:81-91. [Ref.ID 42331]
10.
Kaplan MM. Autonomic disorders and their recognition. N Engl J Med 1997;336:721-3. [Ref.ID 31453]
11. Cita con resumen
Lindor KD, for The Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997;336:691-5. [Ref.ID 31450]
Seleccionar todas
 
 1 a 11 de 11